Triple Moving Average Crossover
|Bid||384.49 x 800|
|Ask||395.00 x 1300|
|Day's Range||385.48 - 391.49|
|52 Week Range||298.69 - 401.78|
|Beta (5Y Monthly)||0.58|
|PE Ratio (TTM)||15.53|
|Forward Dividend & Yield||2.16 (0.55%)|
|Ex-Dividend Date||May 31, 2023|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for MCKLearn more
Tech futures umped up after a debt-ceiling deal. Tesla CEO Elon Musk is in China. Nvidia unveiled new AI offerings.
With artificial intelligence stocks all the rage after Nvidia's blockbuster earnings, Mobileye is among three AI stocks on this weekend's watch list.
McKesson (NYSE: MCK) is one of the largest pharmaceutical distributors in the country. While this isn't the type of investment you might expect 10x returns from, it can provide stability and even reliable dividend income. On the first day of trading in 2018, shares of McKesson closed at $159.
McKesson is Wednesday's IBD Stock Of The Day. Drug distributors are hot and MCK stock is consolidating following a strong quarterly report.
In this article, we will take a look at 14 best healthcare dividend stocks to buy. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks to Buy. The healthcare sector in the US encompasses a wide range of providers, facilities, and […]
You may know Pfizer (NYSE: PFE) for its blockbuster coronavirus vaccine. Pfizer may face a bit of a near-term slowdown in revenue. In fact, Pfizer says these launches should result in $20 billion in sales in 2030.
In this piece, we will take a look at the top fifteen stock picks of billionaire Andreas Halvorsen’s Viking Global. For more stocks, head on over to Billionaire Andreas Halvorsen’s Viking Global Portfolio: Top 5 Stock Picks. The world of investing is full of uncertainty. After all, there’s no such thing as a free lunch, […]
This company is the largest player in the medical distribution industry and is featured in Berkshire Hathaway's investment portfolio.
You don't have to worry about pinpointing an entry point if the underlying company is truly built to last.
McKesson stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 83.
McKesson's (MCK) fiscal fourth-quarter 2023 results benefit from growth in the United States. Divestment hurt the International segment.
It has been said many times before, and it will be many times again: Warren Buffett is the greatest investor of all time. Among the many world-class businesses in Berkshire Hathaway's $345.4 billion investment portfolio, here are two that I think dividend growth investors should strongly consider buying this month. It's no secret that Buffett and his business partner Charlie Munger prefer to invest in businesses that are profitable and possess competitive moats.
At this time, I would like to turn the call over to Nicole Kramer, manager of investor relations. Today, I'm joined by Brian Tyler, our chief executive officer; and Britt Vitalone, our chief financial officer.
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
McKesson (MCK) delivered earnings and revenue surprises of 0.42% and 1.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Inter Parfums' (IPAR) Q1 earnings are expected to reflect gains from robust top-line growth, strength across brands, expansions and product launches.
McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
The COVID-19 public health emergency is slated to end in the U.S. on May 11. Three of the best-performing healthcare stocks since then include Moderna (NASDAQ: MRNA), McKesson (NYSE: MCK), and Eli Lilly (NYSE: LLY). It has multiple products in its approval pipeline, including a vaccine for the respiratory syncytial virus that has been highly effective in late-stage trials.
Staar Surgical (STAA) delivered earnings and revenue surprises of 63.64% and 10.82%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
The healthcare sector includes companies that produce medical goods, such as drugs and medical devices, and companies that provide medical services, such as health insurance or hospital administration.
In the latest trading session, McKesson (MCK) closed at $361, marking a +1.97% move from the previous day.
SmileDirectClub (SDC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardinal Health's (CAH) third-quarter fiscal 2023 results are expected to reflect solid performance in the Pharmaceutical segment. However, inflationary pressure is likely to have continued.
McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.